TET2 and cancer: Ultimately, future biological studies of epigenetic and transcriptomic disruption of candidate gene in cancer may allow us to not only identify new diagnostic and prognostic markers for PCa, but may also provide novel insights into the dynamic changes underlying development and progression in many different cancers exhibiting TET2 dysregulation.